Trial Profile
A Phase 3b Single-Arm, Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Peginesatide (Primary) ; Peginesatide (Primary)
- Indications Anaemia
- Focus Registrational; Therapeutic Use
- Acronyms DIAMOND
- Sponsors Takeda
- 23 May 2014 New trial record